Veterinary Regenerative Medicine Market

Veterinary Regenerative Medicine Market - By Animal Type (Companion, Livestock), Product Type (Stem Cell, [Autologous, Allogenic], Biological Therapy [PRP, GF], Tissue Engineering), Application (Orthopedic, Wound), End-user – Global Forecast (2024 – 2032)

Published Date: May - 2025 | Publisher: MIR | No of Pages: 240 | Industry: Animal Health and Nutrition | Format: Report available in PDF / Excel Format

View Details Buy Now 2890 Download Free Sample Ask for Discount Request Customization

Veterinary Regenerative Medicine Market Size

veterinary regenerative medicine Due of the rising frequency of chronic and degenerative disorders in animals, market size was valued USD 265.5 million in 2023 and is expected to rise at 9.9% CAGR from 2024 to 2032. Both companion and agricultural animals are more prone to conditions including osteoarthritis, ligament injuries, and other age-related diseases.

To get key market trends

  Download Free Sample

For example, the Companion Animal Health study states that among companion animals, osteoarthritis explains at least 80% of lameness and joint disease cases. Although older animals are typically associated with osteoarthritis, a new study on its frequency and clinical symptoms in young canines (aged 8 months to 4 years) revealed 39.8% of these animals showed radiographic evidence of osteoarthritis in at least one joint.

This underlined the major influence of osteoarthritis on different age groups of companion animals, so stressing the need of early intervention plans and appropriate therapies. Furthermore, increasing knowledge among farmers and pet owners about cutting-edge treatment possibilities stimulates demand for regenerative medicine, therefore promoting the expansion of the market.

Veterinary regenerative medicine is the commercial development and implementation of innovative therapies to tissue repair, replacement, or regeneration in animals, therefore addressing damaged tissues and organs. Modern methods include stem cell therapy, biological therapy including platelet-rich plasma (PRP), growth factors, and tissue engineering are used in this discipline to treat many disorders including orthopedic injuries, soft tissue injury, and chronic diseases..

Veterinary Regenerative Medicine Market Report Attributes
Report Attribute Details
Base Year 2023
Veterinary Regenerative Medicine Market Size in 2023 USD 265.5 Million
Forecast Period 2024 – 2032
Forecast Period 2024 – 2032 CAGR 9.9%
2024 – 2032 Value Projection USD 612.8 Million
Historical Data for 2021 – 2023
No. of Pages 180
Tables, Charts & Figures 350
Segments covered Animal Type, Product Type, Application, End-user, and Region
Growth Drivers
  • Rising incidence of chronic and degenerative conditions
  • Growing advancement in regenerative medicine
  • Increasing R&D investment and activities
  • Growing pet ownership and spendings
Pitfalls & Challenges
  • Adverse effects of the treatment
  • Regulatory challenges

What are the growth opportunities in this market?

 Download Free Sample

Veterinary Regenerative Medicine Market Trends

Innovations in stem cell research, tissue engineering, and biologics are significantly enhancing the capabilities and applications of regenerative medicine, leading to more effective and targeted treatments, thereby expanding the market growth in coming years.

  • For example, historically the induction of induced pluripotent stem cells (iPSCs) needed feeder cells from many species, therefore exposing some dangers to the animals undergoing stem cell treatment. Dealing with this difficulty, a group of Osaka Metropolitan University scientists devised a novel technique to reprogram stem cells derived from canine urine. In veterinary regenerative therapy, this non-invasive and pain-free approach represented a major advance. More customized and efficient treatments are made possible by this development opening new avenues for therapies in regenerative medicine and genetic disease research in veterinary science.
  • These kinds of developments are therefore creating major market prospects.
  • Further driving the market demand include the rising animal healthcare spending, improved diagnostics technologies, increasing government backing, and strategic expansions by significant participants.

Veterinary Regenerative Medicine Market Analysis

Learn more about the key segments shaping this market

 Download Free Sample

Based on the animal type, the market is categorized as companion animals and livestock animals. The companion animal segment is set to lead the market, accounting for the largest revenue of USD 158.9 million in 2023, anticipating its dominance throughout the forecast period with a CAGR of 9.8%.

  • The growing trend of pet humanizing resulting to more expenditure on advanced healthcare solutions for pets can help to explain the segment dominance. Furthermore common in companion animals are a variety of disorders like ligament injuries and osteoarthritis, which are amply addressed with regenerative techniques. Consequently, the above mentioned elements help to explain the dominance of the companion animal segment on the market.
  • Moreover, pet owners' increasing acceptance and knowledge of regenerative medicine is driving demand for such therapies and so promoting the expansion of the market.

Learn more about the key segments shaping this market

 Download Free Sample

Based on product type, the veterinary regenerative medicine market is classified into stem cell therapy, biological therapy, and tissue engineering. The stem cell therapy segment holds the largest market share of 60.9% in 2023 and is expected to maintain dominance throughout the analysis period.

  • Stem cell therapy has emerged as the dominant force in the market due to its versatility, efficacy, and broad applicability across various animal health conditions. Stem cells possess a distinct capacity to transform into specialized cell types, accelerating tissue repair and rejuvenation across diverse medical fields including orthopedics, neurology, and dermatology.
  • Further, supported by mounting scientific validation and refinements in isolation methods and quality assurance, stem cell therapy has emerged as the favored option for veterinarians pursuing regenerative remedies for their animal patients.
  • Such aforementioned factor is expected to supplement the segmental growth.

Based on the application, the veterinary regenerative medicine market is segmented into orthopedics, trauma/ wound care, and other applications. The orthopedics segment is projected to reach USD 278.1 million by 2032.

  • The orthopedic segment has asserted dominance due to its high demand for treatments addressing musculoskeletal issues prevalent in companion and livestock animals. Conditions such osteoarthritis and ligament injuries are frequently encountered, prompting a surge in the adoption of regenerative therapies such as stem cell treatments, biological therapies, and tissue engineering.
  • For instance, in January 2023, TVM launched DogStem, a ready-to-use stem cell treatment specifically designed for dogs. DogStem is indicated for treating mild to severe osteoarthritis of the hip and elbow in canines. This innovative treatment aimed to provide an effective solution for managing osteoarthritis, enhancing the outcomes for affected dogs through advanced regenerative therapy. This focus on orthopedic applications reflected the segment dominance in the market.

Based on the end-user, the veterinary regenerative medicine market is segmented into veterinary hospitals, veterinary clinics, and academics and research institutes. The veterinary hospitals segment dominated the market with the highest share in 2023.

  • Because of their complete capacity to provide modern therapies and specialized care, veterinary hospitals controlled most of the market. These hospitals are positioned to provide sophisticated regeneration therapies including stem cell treatments and platelet-rich plasma injections, armed with cutting-edge equipment and manned by qualified veterinarians.
  • Moreover, their capacity to offer integrated and first-rate treatment draws a lot of patients, thereby supporting their market leadership.

Looking for region specific data?

 Download Free Sample

The U.S. dominated the North American veterinary regenerative medicine market accounting for USD 111.3 million in 2023 and is anticipated to show considerable growth over the analysis period.

  • The U.S. holds a leading position in the North American market driven by high pet ownership rates, and significant investment in R&D.  Also, high veterinary healthcare spending in the U.S. tends to further expand the market. For instance, according to the American Pet Products Association, in 2022, pet owners spent USD 31.5 billion on supplies, live animals, and medicine, and USD 35.9 billion on veterinary care and products. Thus, the increasing expenditure on veterinary care is driving the demand for effective treatment options, thereby propelling market growth.
  • Additionally, strong support from regulatory bodies such as the FDA for clinical trials and product approvals further bolsters the U.S. market's growth and innovation.

Germany exhibited a high growth potential in the European veterinary regenerative medicine market.

  • Germany is a key player in the market in Europe, known for its advanced veterinary care and stringent regulatory standards.
  • The country's emphasis on research and technological innovation in veterinary sciences supports the development and adoption of regenerative treatments.
  • In addition, growing awareness among pet owners about advanced therapies and the presence of leading veterinary research institutions and biotechnology companies contribute to Germany's significant role in the market.

The Asia Pacific veterinary regenerative medicine market is poised for rapid growth with a CAGR of 10.4% during the forecast period.

  • The Asia Pacific market is poised for rapid growth due to increasing pet ownership, rising awareness about advanced veterinary treatments, and growing animal healthcare expenditure.
  • Growing investment in veterinary healthcare is driving research for regenerative therapies. Also, advancements in biotechnology and a growing focus on animal health are propelling the adoption of innovative treatments.
  • These factors collectively position the Asia Pacific region poised to expand and explore opportunities in the market.

Veterinary Regenerative Medicine Market Share

The competitive landscape of the veterinary regenerative medicine industry is characterized by numerous established players striving to capitalize on the growing demand for advanced animal healthcare solutions. Key players are dominating the market with their diverse portfolio of regenerative therapies and strong distribution networks. Also, collaborations between academic institutions and industry players for R&D further intensify competition. Furthermore, emerging startups are also making significant strides, leveraging innovative technologies and strategic partnerships to gain traction in this evolving market landscape.

Veterinary Regenerative Medicine Market Companies

Few of the prominent players operating in the veterinary regenerative medicine industry include

  • Animal Cell Therapies, Inc.
  • Ardent
  • Bioceltix
  • Boehringer Ingelheim International GmbH
  • CTSL (Cell Therapy Sciences)
  • Dechra
  • Enso Discoveries
  • Magellan Stem Cells
  • Medrego
  • Regeneus Ltd (Cambium Bio Ltd.)
  • StemcellX
  • VetStem, Inc.
  • Zoetis Inc.

Veterinary Regenerative Medicine Industry News

  • In June 2024, the FDA approved clinical trials at Cornell University Hospital for Animals (CUHA) to explore the use of stem cells in treating musculoskeletal and neurological abnormalities in dogs and horses. The approval aims to enhance animal health by promoting more complete recovery from injuries and reducing discomfort. This significant step forward underscores the potential of regenerative medicine in improving veterinary care outcomes.
  • In April 2024, VetStem, Inc. received FDA review clearance for its PrecisePRP Canine, a leucoreduced, allogeneic, pooled, freeze-dried platelet-rich plasma (PRP). According to the agency, this product is "the first animal cell, tissue, and cell- and tissue-based product (ACTP) intended for intra-articular use to undergo FDA review and receive this determination." The off-the-shelf product approval aimed to mark a significant advancement in veterinary regenerative medicine.

The veterinary regenerative medicine market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments

Click here to Buy Section of this Report

Market, By Animal Type

  • Companion animals
  • Livestock animals

Market, By Product Type

  • Stem cell therapy    
    • Autologous
    • Allogeneic
  • Biological therapy    
    • Platelet-rich plasma (PRP)
    • Growth factors
  • Tissue engineering

Market, By Application

  • Orthopedics
  • Trauma/ wound care
  • Other applications

Market, By End-user

  • Veterinary hospitals
  • Veterinary clinics
  • Academics and research institutes

The above information is provided for the following regions and countries

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Netherlands
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • UAE
    • Rest of Middle East and Africa

 

Related Reports

Table of Content

Will be Available in the sample /Final Report. Please ask our sales Team.

Will be Available in the sample /Final Report. Please ask our sales Team.

FAQ'S

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@marketinsightsresearch.com

Within 24 to 48 hrs.

You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email